Fabrizio Micheli, Verona IT
Fabrizio Micheli, Verona IT
Patent application number | Description | Published |
---|---|---|
20080242715 | Triazolyl Derivatives of Azabicyclo [3.1.0] Hexane as Dopamine D3 Receptor Modulators - The present invention relates to novel compounds of formula (IC) or a salt thereof: | 10-02-2008 |
20080269195 | Compounds Having Affinity For the Dopamine D3 Receptor and Uses Thereof in Medicine - Compounds of formula (I) or a salt thereof are disclosed: | 10-30-2008 |
20080312213 | 7-Pyrazolylbenzazepines Having Affinity For D3 Receptor - Compounds of formula (I) or a salt thereof are disclosed: | 12-18-2008 |
20090030062 | AZABICYCLO [3.1.0] HEXYLPHENYL DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS - The present invention relates to novel compounds of formula (IA) or a salt thereof: | 01-29-2009 |
20090036461 | Use of Azabicyclo Hexane Derivatives - The present invention provides a new use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate salt thereof: | 02-05-2009 |
20090221593 | TRIAZOLE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS - The present invention relates to novel compounds of formula (I) or a salt thereof: | 09-03-2009 |
20090221618 | AZABICYCLO (3, 1, 0) HEXAN DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE D3 RECEPTORS - The present invention relates to novel compounds of formula (I) or a salt thereof: | 09-03-2009 |
20090281135 | 3-AZABICYCLO [4. 1. 0] HEPTANE DERIVATIVES FOR THE TREATMENT OF DEPRESSION - The present invention relates to novel compounds of formula (I) or pharmaceutically acceptable salts, solvates or prodrugs thereof: | 11-12-2009 |
20090326011 | AZAB I CYCLO [3 . 1 . 0] HEXANE DERIVATIVES AS DOPAMIN D3 RECEPTOR MODULATORS - Disclosed herein are compounds of formula (I) | 12-31-2009 |
20100016287 | COMPOUNDS HAVING AFFINITY FOR DOPAMINE D3 RECEPTOR AND USES THEREOF" - Compounds of formula (I) | 01-21-2010 |
20100029740 | AZABICYCLIC COMPOUNDS AS SEROTONIN, DOPAMINE AND NOREPINEPHRINE RE-UPTAKE INHIBITORS - Novel compounds of formula (I)′ and pharmaceutically acceptable salts, solvates and prodrugs thereof: | 02-04-2010 |
20100035914 | AZABICYCLIC COMPOUNDS AS INHIBITORS OF MONOAMINES REUPTAKE - The present invention relates to novel compounds of formula (I)′, and pharmaceutically acceptable salts, prodrugs or solvates thereof: | 02-11-2010 |
20100063078 | SPIROCOMPOUNDS USEFUL AS MODULATORS FOR DOPAMINE D3 RECEPTORS - The present invention relates to novel compounds of formula (I) or salts thereof: | 03-11-2010 |
20100063097 | Azabicyclo [3.1.0] Hexane Derivatives as Modulators of Dopamine D3 Receptors - The present invention relates to certain azabicyclic compounds of formula (I)′: | 03-11-2010 |
20100152195 | Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors - The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt thereof: | 06-17-2010 |
20100160336 | Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors - The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt thereof: | 06-24-2010 |
20120196910 | USE OF AZABICYCLO HEXANE DERIVATIVES - The present invention provides a new use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate salt thereof: | 08-02-2012 |